Functional porous hydrogels to study angiogenesis under the effect of controlled release of vascular endothelial growth factor.
Angiogenesis occurs through a cascade of events controlled by complex multiple signals that are orchestrated according to specific spatial patterns and temporal sequences. Vascularization is a central issue in most tissue engineering applications. However, only a better insight into spatio-temporal signal presentation can help in controlling and guiding angiogenesis in vivo. To this end, versatile and accessible material platforms are required in order to study angiogenic events in a systematic way. In this work we report a three-dimensional porous polyethylene glycol (PEG) diacrylate hydrogel bioactivated with heparin that is able to deliver vascular endothelial growth factor (VEGF) in a sustained and controlled manner. The efficiency of the material has been tested both in vitro and in vivo. In particular, the VEGF released from the hydrogel induces cell proliferation when tested on HUVECs, retains its bioactivity up to 21days, as demonstrated by Matrigel assay, and, when implanted on a chorion allantoic membrane, the hydrogel shows superior angiogenic potential in stimulating new vessel formation compared with unfunctionalized hydrogels. Moreover, in the light of potential tissue regeneration studies, the proposed hydrogel has been modified with adhesion peptides (RGD) to enable cell colonization. The porous hydrogel reported here can be used as a valid tool to characterize angiogenesis, and, possibly, other biological processes, in different experimental set-ups.
Center for Advanced Biomaterials for Health Care, Interdisciplinary Research Centre on Biomaterials, Istituto Italiano di Tecnologia, Largo Barsanti e Matteucci, 80125 Napoli, Italy.
O
O
Oliviero
M
M
Ventre
P A
PA
Netti
D000818:Animals; D002478:Cells, Cultured; D002642:Chick Embryo; D020100:Hydrogels; D008855:Microscopy, Electron, Scanning; D018919:Neovascularization, Physiologic; D011092:Polyethylene Glycols; D042461:Vascular Endothelial Growth Factor A / Q000008:administration & dosage*
D020100:Hydrogels; D042461:Vascular Endothelial Growth Factor A; D011092:Polyethylene Glycols